See analyst estimates and all valuation multiples for Chemicals
Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
---|---|---|---|
$236B | 7.0x | 17.8x | |
$96.1B | 4.1x | 21.3x | |
$84.5B | 5.3x | 22.2x | |
$74.3B | 6.2x | 14.6x | |
$68.9B | 0.9x | 8.0x | |
$53.7B | 3.2x | 8.5x | |
$48.0B | 1.3x | 9.5x | |
$42.6B | 1.5x | 9.3x | |
$41.5B | 2.9x | 14.9x | |
$40.5B | 1.5x | 6.9x | |
$40.2B | 0.9x | 8.5x | |
$39.8B | 7.2x | 3073.7x | |
$37.8B | 3.0x | 11.5x | |
$35.0B | 10.4x | 287.5x | |
$34.4B | 1.0x | 9.7x | |
$32.3B | 6.8x | 18.4x | |
$31.7B | 1.0x | 6.7x | |
$31.2B | 0.8x | 8.7x | |
$29.0B | 1.8x | 10.2x | |
$26.5B | 0.8x | 8.6x | |
$24.7B | 6.3x | 35.2x | |
$24.7B | 1.7x | 9.3x | |
$24.0B | 4.2x | 10.7x | |
$22.3B | 3.4x | 9.4x | |
$22.2B | 1.9x | 11.2x | |
$21.8B | 2.0x | 10.4x | |
$18.7B | 2.2x | 9.4x | |
$18.1B | 4.3x | 14.0x | |
$17.8B | 0.5x | 2.3x | |
$17.3B | 2.3x | 14.4x | |
$16.8B | 1.4x | 9.8x | |
$16.6B | 1.7x | 8.3x | |
$15.9B | 1.0x | 16.0x | |
$15.7B | 2.3x | 5.9x | |
$15.6B | 6.3x | 20.9x | |
$15.5B | 3.1x | 15.0x | |
$15.0B | n/a | n/a | |
$14.8B | 2.6x | 12.0x | |
$14.7B | 3.0x | 11.2x | |
$14.2B | 2.2x | 8.7x | |
$14.1B | 6.0x | 13.1x | |
$13.3B | 1.1x | 8.8x | |
$12.7B | 0.8x | 4.9x | |
$12.2B | 3.7x | 9.3x | |
$11.7B | 1.3x | 7.4x | |
$11.5B | 0.7x | 5.1x | |
$11.3B | 1.2x | 79.8x | |
$11.0B | 0.8x | 11.3x | |
$10.7B | 4.9x | 23.8x | |
$10.0B | 1.3x | 6.6x | |
$8.7B | 1.7x | 7.6x | |
$8.2B | 3.0x | n/a | |
$8.2B | 0.4x | 5.2x | |
$8.0B | 1.5x | 8.3x | |
$7.9B | 0.6x | 2.8x | |
$7.5B | 1.8x | 8.3x | |
$7.5B | 1.3x | 11.4x | |
$7.3B | 0.7x | 4.7x | |
$7.2B | 2.9x | 13.3x | |
$6.8B | 0.7x | 6.4x | |
$6.7B | 2.8x | 8.2x | |
$6.6B | 2.7x | 57.0x | |
$6.6B | 0.8x | 5.8x | |
$6.1B | 0.6x | 7.5x | |
$6.1B | 1.6x | 7.0x | |
$6.0B | 1.0x | 7.6x | |
$5.9B | 0.9x | 7.8x | |
$5.9B | 2.6x | 11.3x | |
$5.7B | 6.1x | 22.9x | |
$5.7B | 2.8x | 11.1x | |
$5.5B | 1.0x | 5.1x | |
$5.3B | 1.3x | 8.6x | |
$5.3B | n/a | n/a | |
$5.1B | 1.5x | 8.4x | |
$5.1B | 6.1x | 21.4x | |
$5.0B | 1.0x | 8.8x | |
$4.9B | 18.7x | 96.7x | |
$4.9B | 1.0x | 5.8x | |
$4.8B | 0.7x | 7.7x | |
$4.8B | 5.1x | 24.3x | |
$4.8B | 4.7x | 17.8x | |
$4.7B | 2.1x | 17.2x | |
$4.7B | 3.0x | 16.6x | |
$4.7B | 1.3x | 7.4x | |
$4.6B | 1.2x | 5.7x | |
$4.6B | 0.7x | 6.3x | |
$4.4B | 1.3x | 8.1x | |
$4.4B | 2.8x | 11.5x | |
$4.3B | 0.4x | 11.7x | |
$4.2B | 1.8x | 13.7x | |
$4.1B | 2.1x | 11.2x | |
$3.9B | 3.8x | 21.7x | |
$3.8B | 0.9x | 15.4x | |
$3.8B | 6.9x | 13.9x | |
$3.7B | 1.3x | 8.6x | |
$3.7B | 1.6x | 7.3x | |
$3.7B | 1.1x | 5.8x | |
$3.5B | 1.9x | 8.8x | |
$3.5B | n/a | n/a | |
$3.5B | 1.7x | 9.2x | |
$3.5B | 0.6x | 11.6x | |
$3.3B | 2.5x | 8.5x | |
$3.3B | n/a | 103.6x | |
$3.1B | 0.4x | 4.9x | |
$3.0B | 1.6x | 10.0x | |
$3.0B | n/a | n/a | |
$2.9B | 10.7x | 32.8x | |
$2.9B | 3.1x | 40.9x | |
$2.8B | n/a | n/a | |
$2.8B | 0.8x | 169.1x | |
$2.6B | 4.3x | 23.4x | |
$2.6B | 0.8x | 8.4x | |
$2.5B | 0.7x | 12.6x | |
$2.4B | n/a | n/a | |
$2.3B | n/a | n/a | |
$2.3B | 0.2x | 7.6x | |
$2.2B | 1.0x | 193.3x | |
$2.1B | 2.8x | 10.9x | |
$2.1B | 2.2x | 11.1x | |
$2.0B | n/a | n/a | |
$2.0B | 0.7x | 6.3x | |
$1.9B | n/a | n/a | |
$1.9B | n/a | n/a | |
$1.9B | 1.4x | 2.9x | |
$1.9B | 1.9x | 10.6x | |
$1.8B | 2.7x | 13.9x | |
$1.8B | n/a | n/a | |
$1.8B | 2.3x | 7.6x | |
$1.7B | 0.4x | 2.5x | |
$1.7B | 0.7x | 8.0x | |
$1.6B | 0.9x | 7.9x | |
$1.6B | 1.7x | 7.3x | |
$1.6B | 0.8x | 6.1x | |
$1.4B | 2.7x | n/a | |
$1.4B | 2.2x | 9.8x | |
$1.4B | n/a | n/a | |
$1.4B | 1.2x | 9.2x | |
$1.3B | 105.5x | n/a | |
$1.3B | 0.7x | 4.8x | |
$1.3B | 0.7x | 31.2x | |
$1.2B | 0.6x | 9.5x | |
$1.2B | 1.8x | 11.1x | |
$1.2B | 0.5x | 24.5x | |
$1.1B | 3.1x | 57.1x | |
$1.1B | 1.3x | 4.7x | |
$1.1B | 1.0x | 2.5x | |
$1.1B | 0.4x | 5.4x | |
$1.0B | 1.0x | 10.1x | |
$980M | 1.8x | 7.1x | |
$914M | 1.1x | 11.3x | |
$910M | 0.6x | 5.2x | |
$881M | 0.4x | n/a | |
$744M | n/a | n/a | |
$732M | 6.2x | 156.0x | |
$633M | n/a | n/a | |
$591M | n/a | n/a | |
$577M | 0.5x | 3.9x | |
$565M | 0.9x | 6.8x | |
$550M | n/a | n/a | |
$537M | 1.9x | -72.3x | |
$535M | 1.2x | 5.9x | |
$513M | 1.4x | 10.4x | |
$505M | 12.1x | 43.6x | |
$485M | 0.7x | 6.4x | |
$482M | 0.4x | 5.9x | |
$476M | 0.9x | 5.7x | |
$420M | 0.8x | 2.5x | |
$406M | 0.7x | 5.5x | |
$358M | n/a | n/a | |
$349M | 1.6x | 9.0x | |
$341M | 0.6x | 8.4x | |
$327M | 1.0x | 9.9x | |
$326M | n/a | n/a | |
$311M | 1.3x | 9.2x | |
$311M | 0.2x | 3.1x | |
$295M | n/a | n/a | |
$291M | 1.2x | 5.3x | |
$286M | n/a | n/a | |
$278M | 9.8x | -6.6x | |
$251M | n/a | n/a | |
$245M | 0.7x | 5.7x | |
$199M | n/a | n/a | |
$199M | 0.6x | 5.6x | |
$198M | 5.0x | 18.1x | |
$195M | 0.2x | 47.2x | |
$191M | 17.4x | -6.1x | |
$191M | n/a | n/a | |
$179M | n/a | n/a | |
$170M | 1.2x | n/a | |
$164M | 0.4x | 4.2x | |
$163M | 152.4x | -171.6x | |
$156M | 0.4x | 3.3x | |
$154M | n/a | n/a | |
$152M | n/a | n/a | |
$144M | 1.2x | 6.6x | |
$140M | 0.6x | 3.9x | |
$128M | n/a | n/a | |
$116M | 5.8x | 17.9x | |
$114M | 1.9x | 98.1x | |
$113M | 8.3x | -4.7x | |
$112M | n/a | n/a | |
$103M | n/a | n/a | |
$97.9M | 110.8x | -2.8x | |
$94.2M | 294.0x | -14.9x | |
$81.7M | 14.1x | -7.8x | |
$80.9M | n/a | n/a | |
$78.4M | n/a | n/a | |
$76.6M | 0.9x | n/a | |
$74.3M | 0.6x | 7.6x | |
$74.0M | n/a | n/a | |
$64.4M | 0.7x | 5.7x | |
$56.6M | n/a | n/a | |
$54.8M | 0.6x | 5.2x | |
$44.2M | 12.2x | -6.9x | |
$43.8M | 0.5x | 17.1x | |
$43.3M | n/a | n/a | |
$40.8M | 0.6x | 14.7x | |
$34.6M | 1.6x | 34.4x | |
$34.3M | n/a | n/a | |
$30.1M | 1.9x | 16.2x | |
$29.0M | n/a | n/a | |
$27.2M | 2.2x | 261.8x | |
$25.9M | n/a | n/a | |
$21.7M | 2.0x | -10.2x | |
$21.2M | n/a | n/a | |
$19.5M | n/a | n/a | |
$19.0M | n/a | n/a | |
$18.2M | n/a | n/a | |
$16.5M | n/a | n/a | |
$16.1M | n/a | n/a | |
$15.7M | n/a | n/a | |
$15.0M | n/a | n/a | |
$12.7M | 2.8x | -6.7x | |
$11.5M | 1.4x | -3.8x | |
$10.4M | n/a | n/a | |
$6.5M | n/a | n/a | |
$5.4M | 4.3x | -6.0x | |
$5.3M | n/a | n/a | |
$5.0M | 15.8x | -6.8x | |
$5.0M | n/a | n/a | |
$4.4M | n/a | n/a | |
$4.4M | n/a | n/a | |
$3.1M | n/a | n/a | |
$2.6M | n/a | n/a | |
$2.5M | 15.7x | -0.7x | |
$2.4M | n/a | n/a | |
$1.7M | n/a | n/a | |
$1.4M | 4.1x | -0.1x | |
$1.4M | n/a | n/a | |
$1.3M | n/a | n/a | |
$1.3M | n/a | n/a | |
$1.2M | n/a | n/a | |
$1.1M | n/a | n/a | |
-$6.0M | n/a | n/a | |
-$21.5M | -0.0x | -0.3x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Chemicals